Eli Lilly pays $1B upfront to buy gene editing partner Verve Therapeutics

Eli Lilly confirms its buyout of Verve Therapeutics after reports about the deal were published by the Financial Times Monday.

Jun 17, 2025 - 13:40
 0
Eli Lilly pays $1B upfront to buy gene editing partner Verve Therapeutics
Eli Lilly confirms its buyout of Verve Therapeutics after reports about the deal were published by the Financial Times Monday.